PFE vs. K
PFE (Pfizer Inc.) and K (Kellogg Company) are both stocks. PFE operates in Drug Manufacturers - General (Healthcare), while K operates in Packaged Foods (Consumer Defensive). At a 0.29 correlation, their price movements are largely independent.
Performance
PFE vs. K - Performance Comparison
Loading charts...
Returns By Period
PFE
- 1D
- 1.36%
- 1M
- 1.40%
- YTD
- 8.09%
- 6M
- 3.39%
- 1Y
- 19.31%
- 3Y*
- -6.48%
- 5Y*
- -2.98%
- 10Y*
- 2.09%
K
- 1D
- —
- 1M
- —
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
PFE vs. K - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
PFE Pfizer Inc. | 8.09% | 0.65% | -2.22% | -41.26% | -10.41% | 66.70% | 3.07% | -6.91% | 24.82% | 15.90% |
K Kellogg Company | 0.00% | 5.99% | 49.75% | -7.44% | 14.35% | 7.44% | -6.78% | 26.08% | -13.32% | -4.93% |
Correlation
The correlation between PFE and K is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.13 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.18 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.19 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.21 |
Correlation (All Time) Calculated using the full available price history since Dec 18, 1984 | 0.29 |
The correlation between PFE and K shifts across timeframes, from 0.13 (1 year) to 0.29 (all time), reflecting how their relationship changes across market environments.
Fundamentals
PFE:
$149.24B
K:
$29.20B
PFE:
$1.31
K:
$3.65
PFE:
19.85
K:
22.87
PFE:
0.36
K:
3.84
PFE:
2.35
K:
2.30
PFE:
1.66
K:
6.95
PFE:
$63.32B
K:
$12.67B
PFE:
$43.91B
K:
$4.41B
PFE:
$16.94B
K:
$2.25B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PFE vs. K — Risk / Return Rank
PFE
K
PFE vs. K - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Pfizer Inc. (PFE) and Kellogg Company (K). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PFE | K | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.17 | — | — |
| Calmar ratioReturn relative to maximum drawdown | 1.79 | — | — |
| Martin ratioReturn relative to average drawdown | 3.68 | — | — |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| PFE | K | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.86 | — | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.12 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.09 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.33 | — | — |
Drawdowns
PFE vs. K - Drawdown Comparison
Loading charts...
Drawdown Indicators
| PFE | K | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -69.24% | — | — |
Max Drawdown (1Y)Largest decline over 1 year | -11.47% | — | — |
Max Drawdown (3Y)Largest decline over 3 years | -40.75% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -58.96% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -58.96% | — | — |
Current DrawdownCurrent decline from peak | -46.03% | — | — |
Average DrawdownAverage peak-to-trough decline | -22.89% | — | — |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.59% | — | — |
Volatility
PFE vs. K - Volatility Comparison
Loading charts...
Volatility by Period
| PFE | K | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.50% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 14.66% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 23.92% | — | — |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 25.50% | — | — |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.88% | — | — |
Dividends
PFE vs. K - Dividend Comparison
PFE's dividend yield for the trailing twelve months is around 6.61%, more than K's 1.39% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
K Kellogg Company | 1.39% | 2.76% | 2.79% | 10.56% | 3.28% | 3.59% | 3.66% | 3.27% | 3.86% | 3.12% | 2.77% | 2.74% |
PFE Pfizer Inc. | 6.61% | 6.91% | 6.33% | 5.70% | 3.12% | 2.64% | 3.92% | 3.68% | 3.12% | 3.53% | 3.69% | 3.47% |
Financials
PFE vs. K - Financials Comparison
This section allows you to compare key financial metrics between Pfizer Inc. and Kellogg Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
PFE vs. K - Profitability Comparison
PFE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported a gross profit of 9.72B and revenue of 14.45B. Therefore, the gross margin over that period was 67.3%.
K - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Kellogg Company reported a gross profit of 1.08B and revenue of 3.26B. Therefore, the gross margin over that period was 33.3%.
PFE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported an operating income of 4.03B and revenue of 14.45B, resulting in an operating margin of 27.9%.
K - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Kellogg Company reported an operating income of 452.00M and revenue of 3.26B, resulting in an operating margin of 13.9%.
PFE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported a net income of 2.69B and revenue of 14.45B, resulting in a net margin of 18.6%.
K - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Kellogg Company reported a net income of 309.00M and revenue of 3.26B, resulting in a net margin of 9.5%.
Frequently Asked Questions
PFE and K have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for PFE and K
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer